49.11
Precedente Chiudi:
$47.66
Aprire:
$47.62
Volume 24 ore:
1.06M
Relative Volume:
0.71
Capitalizzazione di mercato:
$3.01B
Reddito:
$362.27M
Utile/perdita netta:
$-85.19M
Rapporto P/E:
-33.87
EPS:
-1.45
Flusso di cassa netto:
$-68.71M
1 W Prestazione:
-0.26%
1M Prestazione:
+22.10%
6M Prestazione:
+71.41%
1 anno Prestazione:
+4.78%
Twist Bioscience Corp Stock (TWST) Company Profile
Nome
Twist Bioscience Corp
Settore
Industria
Telefono
800-719-0671
Indirizzo
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp
|
49.11 | 2.92B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-04 | Iniziato | Stephens | Overweight |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-06-04 | Iniziato | Guggenheim | Buy |
| 2024-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-09-27 | Iniziato | Berenberg | Buy |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2023-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-29 | Iniziato | William Blair | Outperform |
| 2021-06-04 | Iniziato | Goldman | Neutral |
| 2021-04-12 | Iniziato | Piper Sandler | Overweight |
| 2021-02-05 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-05-31 | Iniziato | Evercore ISI | Outperform |
| 2018-11-26 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Twist Bioscience Corp Borsa (TWST) Ultime notizie
Insider Sell: Adam Laponis Sells 7,000 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience Corporation (NASDAQ:TWST) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Twist's new DNA prep kits salvage low-quality genome samples - Stock Titan
Twist Bioscience (NASDAQ:TWST) Director Sells $105,402.00 in Stock - MarketBeat
Twist Bioscience shareholders approve director elections and executive compensation - Investing.com
Twist Bioscience shareholders approve director elections and executive compensation By Investing.com - Investing.com Australia
Twist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 5,001 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) CAO Robert Werner Sells 7,000 Shares - MarketBeat
Twist Bioscience (TWST) Valuation After Q1 Beat And Raised 2026 Outlook - simplywall.st
Commit To Purchase Twist Bioscience At $37.50, Earn 27.6% Annualized Using Options - Nasdaq
Twist Bioscience Guidance Lift Puts AI Demand And Risks In Focus - Yahoo Finance
Assessing Twist Bioscience (TWST) Valuation After Recent Share Price Momentum - Yahoo Finance
Decoding Twist Bioscience Corp (TWST): A Strategic SWOT Insight - GuruFocus
6 Analysts Assess Twist Bioscience: What You Need To Know - Benzinga
TWST: Evercore ISI Group Raises Price Target on Twist Bioscience - GuruFocus
Barclays Raises Price Target for Twist Bioscience (TWST) to $50 - GuruFocus
These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results - Benzinga
Twist Bioscience Corporation $TWST Stake Raised by Thrivent Financial for Lutherans - MarketBeat
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript - Insider Monkey
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - ChartMill
Twist Bioscience Corporation (TWST): A Bull Case Theory - Finviz
Twist Bioscience Corp SEC 10-Q Report - TradingView
Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Twist Bioscience Q1 2026 slides: Revenue beats guidance, path to profitability accelerates By Investing.com - Investing.com South Africa
Why Is Twist Bioscience Stock Soaring Monday? - Benzinga
Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: S - GuruFocus
Twist Bioscience (NASDAQ:TWST) Shares Gap UpStill a Buy? - MarketBeat
Twist Bioscience (TWST) Stock Surges Over 12% - GuruFocus
Twist Bioscience stock jumps as record quarterly revenue lifts 2026 outlook — what investors watch next - TechStock²
Twist Bioscience (TWST) Boosts Revenue Forecast, Shares Rise - GuruFocus
Twist Bioscience earnings missed by $0.07, revenue topped estimates - Investing.com Canada
Earnings call transcript: Twist Bioscience Q1 2026 sees revenue growth, stock surges - Investing.com India
Twist Bioscience Stock Climbs 7% Over Narrower Loss In Q1 - Nasdaq
Twist Bioscience Q1 2026 Earnings Call Transcript - MarketBeat
Twist Bioscience (TWST) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
TWIST BIOSCIENCE CORP (NASDAQ:TWST) Reports Mixed Q1 FY2026 Results with Revenue Beat and Wider Loss - ChartMill
Twist Bioscience (TWST) Surpasses Revenue Expectations in Q1 - GuruFocus
Twist Bioscience (TWST) Reports Q1 Revenue Beat, EPS Miss - GuruFocus
TWST Reports Impressive Revenue Growth in Latest Financial Update - GuruFocus
Twist Bioscience: Fiscal Q1 Earnings Snapshot - KVUE
Twist Bioscience (TWST) Raises Revenue Forecast for 2026 - GuruFocus
Twist Bioscience Q1 Earnings Report: What Investors Need to Know - Benzinga
Twist Bioscience stock rises 5% on revenue beat, raised guidance - Investing.com
Twist Bioscience Earnings Report: Q1 Overview - Benzinga
Twist Bioscience Corporation $TWST Shares Purchased by New York State Common Retirement Fund - MarketBeat
Twist Bioscience: Overview of First Fiscal Quarter Results - Bitget
Earnings Summary: Twist Bioscience Q1 - Benzinga
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results - Business Wire
Earnings Outlook For Twist Bioscience - Benzinga
Momentum Shift: Can Twist Bioscience Corporation deliver consistent EPS growthPortfolio Performance Report & High Accuracy Investment Signals - baoquankhu1.vn
cathie wood’s ARK stock trades: bullish and kodiak ai bought, kratos defense and twist bioscience sold - Investing.com South Africa
Twist Bioscience Corp Azioni (TWST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):